Back to trial details

Intake questionnaire

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

Applying to UT MD Anderson Cancer Center · Houston, Texas

Answer a few short questions to share with the research team.

0 of 5 answered

1. Are you 18 years old or older?
2. Do you identify as female?
3. Have you been diagnosed with Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia?
4. Are you currently pregnant or breastfeeding?
5. Are you able to travel to Houston for study visits?